Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Peri Q4 Earnings Misses Estimates By 0.03 20260401 Can Pagaya Pgy Stock Rebound In 2026 Price At 11.96 Up 2.18 20260413 Will Ccsc Tech Cctg Stock Beat Expectations Price At 0.44 Up 4.29 20260408 Is Novonix Nvx Stock A Value Play Price At 0.69 Up 5.69 20260406 PMTV PennyMac Mortgage Investment Trust 900 Senior Notes due 2030 Q4 2025 EPS outperforms estimates shares edge slightly higher today Why MT Bank MTBK guidance matters more than actual results MTBK Q4 Earnings Series K Preferred Dividend Declared ARMOUR REIT ARR Stock Why Pricing Power Recovers 20260416 Chanson CHSN Stock Downside Volume Jumps 20260416 RF RFAI Stock Accelerating Slow Grind 20260420 Swvl SWVL Stock Should You Build a Position 1203 20260420 How CelSci CVM performance reflects its true potential Breakdown Watch 20260511 Takeda TAK Stock Why It Could Change Breakdown Watch 20260420 Why Embecta EMBC deserves a spot in every portfolio Technical Strength 20260508 RMD ResMed posts narrow Q1 2026 EPS beat as shares fall 24 percent amid tepid investor sentiment InflaRx NV IFRX stock jumps 6 despite 82 revenue decline EPS beats estimates by 2 FITBM Fifth posts 35 percent EPS surprise in Q1 2026 shares stay flat in todays trading Zydus Wellness Reports FY26 Net Profit Drop to 197 Crore Despite 46 Revenue Surge AlphaTON ATON Stalls at 032 Breakout or Breakdown 20260515 US Stock Market Navigates Renewed Volatility as Analysts Assess Shifting Economic Landscape Ultrapar UGP Crushes Q1 2026 Estimates EPS 080 Tops Views Henry Schein HSIC Stock Analysis Flat at 7262 Whats Next 20260515 Silicon SVAQ Stock Analysis RangeBound Near 994 20260519 Middle East Conflict Impacts LVMH LVMUY Performance in Q1 2026 Says Broyhill Asset Management Musk Loses OpenAI Court Battle After Jury Finds He Waited Too Long to Sue Ubisoft Shares Decline After Assassins Creed Developer Warns of Continued Losses Alphabets AI Showcase at Google IO Wall Street Watches for Product Roadmap Spain Accelerates Reindustrialisation 76 of Firms Adopt Strategy as AI Investment Plans Rise TPG Mortgage Investment Trust Inc 9500 Senior Notes due 2029 MITP Q1 2026 Earnings EPS Beats Estimates with 535 Surprise Modest Stock Gain Ledn Projects 1 Trillion Market for BitcoinBacked Loans Potential SpaceX IPO Could Reshape RecordBreaking Stock Market Debuts Pfizer Prevails in Singapore Trademark Dispute with Merck Over Vaccine Brand Waterfield Advisors Equities Head Suggests Staggered Accumulation as Peak Macro Concerns Subside SafeHaven Surge Swiss Franc and Japanese Yen Strengthen as DeepSeek AI News Rattles US Tech Stocks Lowes Warns of Shifting Consumer Sentiment Amid Housing Market Headwinds eBay Q1 2026 Earnings EPS Beats Estimates as Stock Declines Amid Revenue Uncertainties Innventure Inc Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Limited Revenue Disclosure ICMB Q3 2025 Earnings EPS Falls Short of Estimates Stock Edges Higher TOL Q1 2026 Earnings Earnings Beat Expectations as Homebuilder Navigates Market Conditions ORCL Q1 2026 Earnings EPS Beats Estimates Amid Strong Cloud Momentum SABS Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development Shares Edge Higher Oaktree Specialty Lending Corporation OCSL Edges Higher as Support Holds Steady Solaris Energy Infrastructure SEI Gains 114 as Shares Hold Above Key Support Newbridge Acquisition Unit NBRGU Edges Higher Support and Resistance Levels in Focus Repay Holdings RPAY Holds Steady Near Support Amid Modest Uptick Real Asset Acquisition Corp Warrants RAAQW Drift Lower as Trading Remains Subdued Monro MNRO Stock Analysis Buy or Sell Monro Inc delivers 154 EPS beat on solid auto demand Chart Industries GTLS Stock Why It Could Trend Momentum Fading 20260416 TEM Tempus AI Inc tops EPS estimates and posts 83 percent year over year revenue growth shares fall 353 percent today AAR Corp AIR Future Outlook AAR Corp posts 74 EPS beat on solid aero demand ERNA shares fall 371 as Ernexa Therapeutics posts Q3 loss of 103 per share